tiprankstipranks
Trending News
More News >
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market

Chimeric Therapeutics Ltd. (CHM) Financial Statements

Compare
14 Followers

Chimeric Therapeutics Ltd. Financial Overview

Chimeric Therapeutics Ltd.'s market cap is currently AU$11.05M. The company's EPS TTM is AU$-0.004; its P/E ratio is ―; Chimeric Therapeutics Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 3.97MAU$ 7.46MAU$ 0.00AU$ 2.62MAU$ 2.65K
Gross ProfitAU$ 3.12MAU$ 7.45MAU$ 3.54MAU$ 1.67MAU$ -844.31K
Operating IncomeAU$ -15.11MAU$ -12.31MAU$ -29.49MAU$ -14.57MAU$ -14.85M
EBITDAAU$ -9.08MAU$ -11.30MAU$ -28.59MAU$ -13.62MAU$ -14.26M
Net IncomeAU$ -10.43MAU$ -12.53MAU$ -25.92MAU$ -15.90MAU$ -15.11M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 5.76MAU$ 3.05MAU$ 5.37MAU$ 18.38MAU$ 22.41M
Total AssetsAU$ 21.57MAU$ 15.27MAU$ 22.38MAU$ 34.88MAU$ 36.50M
Total DebtAU$ 0.00AU$ 3.59MAU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -5.76MAU$ -3.05MAU$ -5.37MAU$ -18.38MAU$ -22.41M
Total LiabilitiesAU$ 19.60MAU$ 12.80MAU$ 16.71MAU$ 9.17MAU$ 11.37M
Stockholders' EquityAU$ 1.97MAU$ 2.47MAU$ 5.66MAU$ 25.71MAU$ 25.13M
Cash Flow
Free Cash FlowAU$ -7.28MAU$ 10.11KAU$ -16.43MAU$ -13.69MAU$ -14.15M
Operating Cash FlowAU$ -7.28MAU$ -7.54MAU$ -16.32MAU$ -13.15MAU$ -8.84M
Investing Cash FlowAU$ 0.00AU$ 0.00AU$ -112.19KAU$ -577.86KAU$ -5.30M
Financing Cash FlowAU$ 10.05MAU$ 8.26MAU$ 253.38KAU$ 9.50MAU$ 36.54M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

Chimeric Therapeutics Ltd. Debt to Assets

Chimeric Therapeutics Ltd. Cash Flow

Chimeric Therapeutics Ltd. Forecast EPS vs Actual EPS